ReviewCell death discovery2021

Genome-scale CRISPR-Cas9 knockout screening in hepatocellular carcinoma with lenvatinib resistance.

Yonggang Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.